Human papillomavirus E1 proteins inhibit RIG-I/MDA5-MAVS, TLR3-TRIF, cGAS-STING, and JAK-STAT signaling pathways to evade innate antiviral immunity
Human papillomavirus (HPV) is a major etiological agent of both malignant and benign lesions, with high-risk types, such as HPV16 and HPV18, being strongly linked to cervical cancer, while low-risk types like HPV11 are associated with benign conditions. While viral proteins such as E6 and E7 are wel...
Saved in:
| Main Authors: | Jin-Xin Li, Jing Zhang, Cheng-Hao Li, Yun-Fang Li, Hui-Min Chen, Tao Li, Qing Zhang, Bei-Hua Kong, Pei-Hui Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1549766/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Helicase protein DDX11 as a novel antiviral factor promoting RIG-I-MAVS-mediated signaling pathway
by: Jiyu Zhang, et al.
Published: (2024-12-01) -
An intracellular bacterial pathogen triggers RIG-I/MDA5-dependent necroptosis
by: Hang Xu, et al.
Published: (2024-01-01) -
RIG-I and cGAS mediate antimicrobial and inflammatory responses of primary osteoblasts and osteoclasts to Staphylococcus aureus
by: Erin L. Mills, et al.
Published: (2025-05-01) -
A targeted MAVS fusion protein for controlled innate immune activation and antitumor therapy
by: Muhan Wang, et al.
Published: (2025-12-01) -
TXNIP promotes viral replication by disrupting MAVS-mediated antiviral signaling and serves as a therapeutic target for antiviral therapy
by: Ruilin Chen, et al.
Published: (2025-09-01)